Riskpilot← Back to searchSign inGet full accessVitamed AB
ABActiveOrg 5568354103Turistgatan 41General medical practice activities · NACE 8621Est. 20102 employees
Revenue 2025
SEK 3,5M
+3% vs 2024
EBITDA margin
43.5%
+6% vs 2024
Equity ratio
49.8%
Financial strength
Net profit 2025
SEK 1M
+24% vs 2024
| Revenue | SEK 3,5M | +3% |
| EBITDA | SEK 1,5M | +6% |
| Net profit | SEK 1M | +24% |
| Total assets | SEK 4,2M | +19% |
| Equity | SEK 2,1M | +25% |
| Employees | 2 | — |
Legal name
Vitamed AB
Org number
5568354103
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 december 2010
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkarverksamhet, konsultverksamhet inom medicin, personalrekrytering inom sjukvården (läkare, sköterskor, sjukgymnaster), bedriva äldreboende, vårdcentral, äga och förvalta värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Turistgatan 41
Email
mi.jaszczak@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 3 238 | 3 025 | 3 205 | 3 093 | 3 125 | 3 086 | 3 391 | 3 509 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −1 624 |
| EBITDA | 1 694 | 938 | 1 403 | 1 302 | 1 192 | 1 384 | 917 | 561 | 1 436 | 1 526 |
| Depreciation & amort. | −238 | −154 | −197 | −214 | −66 | −36 | −36 | −32 | −17 | −13 |
| EBIT | 1 456 | 784 | 1 206 | 1 088 | 1 126 | 1 348 | 881 | 529 | 1 419 | 1 513 |
| Net financials | −26 | −17 | −17 | −14 | −6 | −1 | — | 1 | 1 | 0 |
| Profit before tax | 1 072 | 767 | 893 | 805 | 838 | 1 009 | 922 | 827 | 1 070 | 1 333 |
| Tax | −236 | −169 | −197 | −173 | −180 | −209 | −196 | −180 | −227 | −284 |
| Net profit | 836 | 598 | 696 | 632 | 658 | 800 | 726 | 647 | 843 | 1 049 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 910 | 1 590 | 2 443 | 2 537 | 2 582 | 3 072 | 3 148 | 2 923 | 3 545 | 4 219 |
| Equity | 1 011 | 882 | 905 | 928 | 1 002 | 1 232 | 1 433 | 1 460 | 1 682 | 2 099 |
| Long-term debt | 372 | 192 | 400 | 50 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 170 | 159 | 484 | 637 | 376 | 298 | 214 | 259 | 308 | 385 |
| Total debt | 542 | 351 | 884 | 687 | 376 | 298 | 214 | 259 | 308 | 385 |
EBITDA margin
43.5%
This company
15.8%
Market median
+175% vs market
20162025
Equity ratio
49.8%
This company
38.2%
Market median
+30% vs market
20162025
Return on equity
50.0%
This company
18.4%
Market median
+172% vs market
20162025
Net profit margin
29.9%
This company
8.1%
Market median
+269% vs market
20162025
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20162025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MM | Audit | 2026 | — | — |
LF Chief Auditor | Chief Auditor | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitamed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Madeleine Lundström | Audit | 0 companies |
| Lars Fredrik Lundgren | Chief Auditor | 0 companies |
| Joanna Jaszczak | Deputy Board Member | 0 companies |
| Michal Maciej Jaszczak | Board of Directors | 0 companies |